Chief Scientific Officer of Homology Medicines, Inc. (NASDAQ:FIXX), Seymour Albert, sells 10,000 shares worth $114,422
According to Homology Medicines, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jan 07 04:05 PM, company Chief Scientific Officer, Seymour Albert disclosed selling 10,000 shares at a cost of $11.44. At the time of this transaction (Jan 05), this trade was worth $114,422 in total. As of Jan 05, Seymour Albert now owns 144,017 shares in total worth about $1,810,293.69.
For the last few recent trades made by Homology Medicines, Inc. (NASDAQ:FIXX) Chief Scientific Officer, Seymour Albert, we have the following information:
- SEC Form 4 filing: Jan 02: Sold 9,133 shares at the rate of $20.50 per share. Total worth of this trade was $187,216. Total number of shares owned as of Jan 02 were 154,017
- SEC Form 4 filing: Nov 29: Sold 9,300 shares at the rate of $16.06 per share. Total worth of this trade was $149,390. Total number of shares owned as of Nov 29 were 172,450
- SEC Form 4 filing: Dec 02: Sold 9,300 shares at the rate of $16.23 per share. Total worth of this trade was $150,970. Total number of shares owned as of Dec 02 were 163,150
Posted by
George Daniels
on Thursday January 07 2021, 6:17 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
